Workflow
Fuerjia Technology(301371)
icon
Search documents
纬德信息:1月16日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2026-01-16 10:05
每经头条(nbdtoutiao)——白银50天涨逾80%,疯狂程度远超黄金,历史上爆炒白银往往预示贵金属 牛市已到高潮,这次有何不同? (记者 胡玲) 每经AI快讯,纬德信息1月16日晚间发布公告称,公司第三届第四次董事会会议于2026年1月16日以通 讯形式召开。会议审议了《关于购买控股子公司部分少数股权暨关联交易的议案》等文件。 ...
化妆品板块1月15日跌0.36%,水羊股份领跌,主力资金净流出1186.31万元
Market Overview - The cosmetics sector experienced a decline of 0.36% on January 15, with Shuiyang Co. leading the drop [1] - The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1] Individual Stock Performance - Jinsheng New Material (300849) saw a significant increase of 13.17%, closing at 18.48 with a trading volume of 117,000 shares and a turnover of 209 million yuan [1] - Qingdao Kingway (002094) increased by 2.06%, closing at 8.42 with a trading volume of 1,113,500 shares [1] - Lafang Home (603630) rose by 1.76%, closing at 24.27 with a trading volume of 137,300 shares [1] - Other notable performances include Fulejia (301371) up 0.73%, Marubi Biological (603983) up 0.70%, and Betaini (300957) up 0.32% [1] Capital Flow Analysis - The cosmetics sector saw a net outflow of 11.86 million yuan from institutional investors and 53.27 million yuan from retail investors, while retail investors had a net inflow of 65.13 million yuan [2] - The capital flow for individual stocks indicates that Lafang Home had a net inflow of 77.73 million yuan from institutional investors, while Betaini had a net inflow of 14.81 million yuan [3] - Conversely, Shuiyang Co. experienced a net outflow of 5.39 million yuan from institutional investors [2][3]
敷尔佳:截至2026年1月9日股东户数为16247户
Zheng Quan Ri Bao Wang· 2026-01-12 12:45
证券日报网讯1月12日,敷尔佳(301371)在互动平台回答投资者提问时表示,截至2026年1月9日,公 司股东户数为16247户。 ...
化妆品板块1月9日涨1.29%,水羊股份领涨,主力资金净流出3172.78万元
Market Overview - The cosmetics sector increased by 1.29% on January 9, with Shuiyang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Individual Stock Performance - Shuiyang Co., Ltd. (300740) closed at 25.65, up 5.90% with a trading volume of 223,500 shares and a transaction value of 561 million yuan [1] - Qingsong Co., Ltd. (300132) closed at 8.70, up 2.47% with a trading volume of 253,700 shares [1] - Beitaini (300957) closed at 41.20, up 1.85% with a trading volume of 163,500 shares and a transaction value of 261 million yuan [1] - Other notable stocks include Furuida (600223) at 7.53 (+1.76%), Jiaheng Jiahua (300955) at 39.89 (+1.68%), and Huaye Fragrance (300886) at 26.64 (+1.06%) [1] Capital Flow Analysis - The cosmetics sector experienced a net outflow of 31.72 million yuan from institutional investors and 34.45 million yuan from speculative funds, while retail investors saw a net inflow of 66.18 million yuan [2] - Individual stock capital flows indicate that Qindao Jinwang (002094) had a net inflow of 13.96 million yuan from institutional investors, while it faced a net outflow of 1.23 million yuan from speculative funds [3] - Other stocks like Qingsong Co., Ltd. (300132) and Beitaini (300957) also showed mixed capital flows, with varying levels of net inflows and outflows from different investor categories [3]
敷尔佳:目前全渠道价差整体可控
Zheng Quan Ri Bao Wang· 2026-01-08 13:43
证券日报网1月8日讯,敷尔佳(301371)在接受调研者提问时表示,目前全渠道价差整体可控,主流渠 道间波动基本维持在合理区间,大促期间会通过满减、加赠等方式平衡销量与价盘。 ...
敷尔佳:公司2025年有一款Ⅲ类医疗器械已经进入临床阶段
Zheng Quan Ri Bao Wang· 2026-01-08 13:43
Core Viewpoint - The company Fuhua (301371) is progressing in its R&D projects, with specific timelines and developments for its medical devices and injectable products outlined for 2025 [1] R&D Progress - The company has a Class III medical device, "Recombinant Type III Humanized Collagen Dressing," which has entered the clinical stage for 2025 [1] - For injectable products, the clinical trials for the "Recombinant Type III Humanized Collagen Lyophilized Fiber" project have been completed, and the company is preparing the clinical trial summary report [1] - The "Recombinant Type III Humanized Collagen Gel" project is still in the R&D phase, with plans to initiate clinical trials this year [1] - Further updates on other R&D projects will be available in the annual report scheduled for release in April [1]
敷尔佳:公司两个月合计上新18款产品
Zheng Quan Ri Bao Wang· 2026-01-08 13:13
证券日报网1月8日讯,敷尔佳(301371)在接受调研者提问时表示,从2025年11-12月的上新数据看, 两个月合计上新18款产品(含旧品升级),械品和妆品各占9款,具体产品情况可到公司在各大电商平台 开设的官方旗舰店查询;从2026年的上新计划看,械品和妆品都有,具体以实际上新情况为准。 ...
敷尔佳:从2025年前三季度销售数据看,线下数据受销售渠道优化调整的影响较大
Zheng Quan Ri Bao Wang· 2026-01-08 13:13
Core Viewpoint - The company is currently finalizing its financials and will disclose specific data in its annual report on April 23. The sales data for the first three quarters of 2025 indicates significant impact from the optimization of offline sales channels, which the company is actively adjusting to ensure long-term healthy development of its offline business [1] Group 1 - The company is transitioning its offline sales model from traditional distribution to a value-driven sales approach to create better conditions for long-term growth [1] - The optimization of offline sales channels is showing noticeable effects, although it may take time for sales data to reflect this change [1] - The company believes that as the channel model transforms and the offline market stabilizes, both distributors and sales terminals will improve, leading to healthy growth in the company's offline business [1]
敷尔佳:公司进行产品结构调整是为了顺应消费市场趋势、契合公司业务发展、完善产品矩阵
Zheng Quan Ri Bao Wang· 2026-01-08 13:13
证券日报网1月8日讯,敷尔佳(301371)在接受调研者提问时表示,公司进行产品结构调整是为了顺应 消费市场趋势、契合公司业务发展、完善产品矩阵。毛利率的阶段性波动,主要受行业竞争加剧带来的 促销环境变化影响,叠加产品结构切换过程中高毛利产品占比自然下降、新拓展品类前期规模效应尚未 完全释放的客观情况。后续,公司会从生产方式、产品定价、供应链管理等方面进行优化与改善,毛利 率短期波动属正常调整。 ...
敷尔佳:线下渠道调整已取得阶段性成效
Zheng Quan Ri Bao· 2026-01-08 13:11
Core Viewpoint - The company has achieved preliminary success in optimizing its offline channels, focusing on sales channel and retail terminal improvements, with financial feedback showing some lag [2] Group 1: Channel Optimization - The company is enhancing cooperation with service-oriented distributors through a dual approach of "strong regulation + strong optimization" to strengthen market control [2] - The focus is on meticulous management of inventory levels at both distributors and retail terminals to avoid excess stock risks, alongside comprehensive and ongoing dynamic regulation of the pricing system across all channels to maintain price order stability [2] - The strategy includes careful selection of strategic partners among distributors and retail terminals, transitioning the channel model from traditional distribution to value-driven sales [2] Group 2: Short-term Impact and Future Development - The short-term impact of the offline adjustments on performance is manageable, serving as a foundational project for the company's future high-quality development [2]